Entries by connective

Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting

Cambridge, UK: Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 20 March 2023 of its final results for the year ended 31 December 2022 on Form 20-F with the Securities and Exchange Commission, the Abcam plc Annual Report and Accounts 2022 (the “Annual Report”) […]

Final results for the year ended 31 December 2022

15% Reported Revenue Growth & 8% Constant Exchange Rate Revenue Growth: Demand for Abcam In-house Products Continues 20 March 2023, Cambridge, UK – Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its results for the year ended 31 December 2022 […]

Abcam to Report Full Year Results on Monday, March 20, 2023

10, March 2023, Cambridge, UK – Abcam plc (Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report its results for the year ended 31 December 2022 at 7.00 a.m. ET on 20 March 2023. Following the announcement, the Company will host a live teleconference and […]

Trading Update

Cambridge, UK: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the year ending 31 December 2022. Abcam concluded the third year of its five-year growth plan by further building capabilities to drive long term and profitable growth. […]

Abcam Unveils New Plaques to Honour Team Behind Breast Cancer Gene Discovery

Members of the team that identified the BRCA2 gene came to unveil the plaque at the Institute of Cancer Research’s Chelsea site Cambridge, UK, 25 January 2023 – Ahead of World Cancer Day – Saturday 4th February – the team of 41 scientists behind the landmark discovery of the BRCA2 breast cancer gene have been celebrated […]

WuXiDiagnostics and Abcam expand existing collaboration to advance companion diagnostics for cancer therapies

  Shanghai, China and Cambridge, UK – 13 December, 2022 – WuXiDiagnostics, an enabling platform company that implements integrated diagnostics and Abcam (AIM:ABC; NASDAQ:ABCM), a global life science company working together with researchers to advance science and enable faster breakthroughs, today announced a new supply and licensing agreement in the area of companion diagnostic reagents […]

Biomarkers UK

Biomarkers UK 08 – 09 November 2021 Manchester, UK / Hybrid